G1 Therapeutics (GTHX)
(Delayed Data from NSDQ)
$4.09 USD
-0.13 (-3.08%)
Updated May 24, 2024 03:59 PM ET
After-Market: $4.08 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, G1 Therapeutics (GTHX) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.19 per share. This reflects a negative earnings surprise of 5.26%. Look out for GTHX's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year decrease of 221.43%.
Earnings History
Price & Consensus
Zacks News for GTHX
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
GTHX: What are Zacks experts saying now?
Zacks Private Portfolio Services